Article

Drug shortage webinar

Author(s):

Although President Obama issued an executive order last week to tackle the growing shortages of some medicines, the results of that order may not come fast enough for many cancer patients in need of treatments. More than 22 chemotherapy drugs, about 35 to 40 percent of the total number of approved cancer drugs, are in short supply. To support cancer patients' concerns and provide help, Fight Colorectal Cancer is hosting a free webinar on the drug shortages called "What to do when your doc is out of 5-FU (or leucovorin or irinotecan)" on November 16 at 8:00 p.m. (EST). Dr. Lindsey Poppe, the pharmacy clinical manager of oncology for the University of North Carolina hospital system, will provide alternatives and advice for patients and discuss how to take action to get your government representatives involved in a resolution. To participate, register here. After Nov. 16, the webinar can be accessed at fightcolorectalcancer.org.

Related Videos
.Dr. Catherine Wu, chief of the Division of Stem Cell Transplantation and Cellular Therapies at Dana-Farber Cancer Institute, and institute member at the Broad Institute of MIT and Harvard, in Boston
Image of Doctor with blonde hair.
Dr. Katy Beckermann discusses how a Fotivda and Opdivo combination for renal cell carcinoma compared with Fotivda alone based on patient feedback.
Dr. Petros Grivas discusses what precautions should be considered when treating patients with advanced urothelial carcinoma who have diabetes.
Dr. Debu Tripathy discussed the importance of understanding the distinctions between HER2-low and HER2-ultralow breast cancer.
Primary urothelial cancer has variable histologies, making its treatment complex, leading to varied outcomes with high rates of recurrence in patients.
Dr. Neeraj Agarwal is a medical oncologist, a professor of medicine and the Presidential Endowed Chair of Cancer Research at the Huntsman Cancer Institute, University of Utah, as well as director of the Genitourinary Oncology Program and the Center of Investigational Therapeutics at the Huntsman Cancer Institute in Salt Lake City.
Image of Dr. Goy.
Image of bald man.
Dr. Tycel Phillips is an Associate Professor in the Division of Lymphoma, Department of Hematology and Hematopoietic Cell Transplantation, at City of Hope in Duarte, California.
Related Content